Until recently, local stem cells were thought to be the sole sources for epithelial repopulation following lung injury. However, an increasing body of data indicates a role for bone marrow derived stem cells (BMSCs) in this process. The scant literature in this area has been largely anecdotal. To date, no study has systematically analyzed the conditions necessary for stem cell to lung engraftment, or even confirmed that these marrow derived cells are functional. Asking these questions is important because, if answered, they will yield information on how to use BMSCs as a renewable pool of pneumocyte precurors and open up new horizons of treatment for currently intractable respiratory disorders. Such a goal would include use of allogeneic marrow transplant or even genetically modified/peripherally mobilized autologous BMSCs to treat inherited or acquired diseases of the respiratory tract such as alpha-1 antitrypsin deficiency or pulmonary fibrosis. To address these issues, this grant proposes to work use the sponsorship of Dr. Diane Krause to clarify the role that BMSCs play in lung repair. Dr. Krause is a leader in this field whose successful mentoring has enabled her previous fellows to pursue academic careers.
The aims herein will investigate the capacity of both transplanted and nontransplanted marrow to become lung epithelia and determine if BMSCs can transfer a functional gene to the respiratory epithelium. They also explore a role for the use of BMSCs to modulate the healing response in a fibrotic murine models of human lung disease. These questions will be explored using transgenic mouse models, single cell analysis of pneumocytes using flow cytometry and immunohistochemical techniques, assessment of marrow origin in situ hybridization, and analysis of stem cell contributions to lung repair on a number of biochemical, molecular and functional levels.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Clinical Investigator Award (CIA) (K08)
Project #
1K08HL079066-01
Application #
6859110
Study Section
Special Emphasis Panel (ZHL1-CSR-M (O1))
Program Officer
Colombini-Hatch, Sandra
Project Start
2004-12-17
Project End
2009-11-30
Budget Start
2004-12-17
Budget End
2005-11-30
Support Year
1
Fiscal Year
2005
Total Cost
$140,400
Indirect Cost
Name
Yale University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
043207562
City
New Haven
State
CT
Country
United States
Zip Code
06520
Russell, Thomas M; Herzog, Erica L; Bucala, Richard (2012) Flow cytometric identification of fibrocytes in scleroderma lung disease. Methods Mol Biol 900:327-46
Gan, Ye; Reilkoff, Ronald; Peng, Xueyan et al. (2011) Role of semaphorin 7a signaling in transforming growth factor ?1-induced lung fibrosis and scleroderma-related interstitial lung disease. Arthritis Rheum 63:2484-94
Murray, Lynne A; Chen, Qingsheng; Kramer, Michael S et al. (2011) TGF-beta driven lung fibrosis is macrophage dependent and blocked by Serum amyloid P. Int J Biochem Cell Biol 43:154-62
Herzog, Erica L; Bucala, Richard (2010) Fibrocytes in health and disease. Exp Hematol 38:548-56
Mathai, Susan K; Gulati, Mridu; Peng, Xueyan et al. (2010) Circulating monocytes from systemic sclerosis patients with interstitial lung disease show an enhanced profibrotic phenotype. Lab Invest 90:812-23
Homer, Robert J; Herzog, Erica L (2010) Recent advances in pulmonary fibrosis: implications for scleroderma. Curr Opin Rheumatol 22:683-9
Herzog, Erica L; Brody, Arnold R; Colby, Thomas V et al. (2008) Knowns and unknowns of the alveolus. Proc Am Thorac Soc 5:778-82
Herzog, Erica L; Van Arnam, John; Hu, Buqu et al. (2007) Lung-specific nuclear reprogramming is accompanied by heterokaryon formation and Y chromosome loss following bone marrow transplantation and secondary inflammation. FASEB J 21:2592-601
Herzog, Erica L; Van Arnam, John; Hu, BuQu et al. (2006) Threshold of lung injury required for the appearance of marrow-derived lung epithelia. Stem Cells 24:1986-92